In 433 patients undergoing breast surgery, median VAS pain scores declined from 2 on day 1 to 0 by day 30, with severe pain in only 7.4% and opioid use in 2.5%, supporting nonopioid-based analgesic protocols.
Gokturk Maralcan
Advertisement
Articles by Gokturk Maralcan
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Pirtobrutinib Earns Positive CHMP Opinion Across All CLL Treatment Lines
2
Generic Enzalutamide Receives Tentative FDA Approval in Prostate Cancer
3
Teclistamab Induction Shows Feasibility in Transplant-Eligible Myeloma
4
40 An AI Digital Twin Compares Favorably to Radiologists for Landmark Identification and Measurement in Early-Stage Breast Cancer: A Retrospective, Multi-Institution Clinical Study
5